Acebrochol: Difference between revisions
Content deleted Content added
added CSID, (Std)InChI & (Std)InChIKey |
Entranced98 (talk | contribs) +sd |
||
(18 intermediate revisions by 11 users not shown) | |||
Line 1: | Line 1: | ||
{{short description|Chemical compound}} |
|||
{{Drugbox |
{{Drugbox |
||
| Verifiedfields = changed |
|||
⚫ | |||
| Watchedfields = changed |
|||
⚫ | |||
| IUPAC_name = [(4S,6R,8S,9S,10R,13R,14S,17R)-4,6-dibromo-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate |
| IUPAC_name = [(4S,6R,8S,9S,10R,13R,14S,17R)-4,6-dibromo-10,13-dimethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-3-yl] acetate |
||
| image = Acebrochol. |
| image = Acebrochol.svg |
||
<!--Clinical data--> |
<!--Clinical data--> |
||
| tradename = |
| tradename = |
||
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X --> |
||
| pregnancy_US = <!-- A / B / C / D / X --> |
| pregnancy_US = <!-- A / B / C / D / X --> |
||
| pregnancy_category = |
| pregnancy_category = |
||
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled--> |
||
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
| legal_CA = <!-- Schedule I, II, III, IV, V, VI, VII, VIII --> |
||
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
| legal_UK = <!-- GSL, P, POM, CD, or Class A, B, C --> |
||
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V --> |
||
| legal_status = |
| legal_status = |
||
| routes_of_administration = |
| routes_of_administration = |
||
<!--Pharmacokinetic data--> |
<!--Pharmacokinetic data--> |
||
| bioavailability = |
| bioavailability = |
||
| protein_bound = |
| protein_bound = |
||
| metabolism = |
| metabolism = |
||
| elimination_half-life = |
| elimination_half-life = |
||
| excretion = |
| excretion = |
||
<!--Identifiers--> |
<!--Identifiers--> |
||
| CAS_number_Ref = {{cascite|correct|??}} |
|||
| CAS_number = 514-50-1 |
| CAS_number = 514-50-1 |
||
| ATC_prefix = none |
| ATC_prefix = none |
||
| ATC_suffix = |
| ATC_suffix = |
||
| ATC_supplemental = |
| ATC_supplemental = |
||
| PubChem = 170366 |
|||
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
| DrugBank_Ref = {{drugbankcite|correct|drugbank}} |
||
| DrugBank = |
| DrugBank = |
||
| ChEMBL_Ref = {{ebicite|changed|EBI}} |
|||
| ChEMBL = 2104033 |
|||
| UNII_Ref = {{fdacite|correct|FDA}} |
| UNII_Ref = {{fdacite|correct|FDA}} |
||
| UNII = 7XZB016MY5 |
| UNII = 7XZB016MY5 |
||
| PubChem = 170366 |
|||
| |
| PubChem = 10952056 |
||
| ChemSpiderID_Ref = {{chemspidercite|changed|chemspider}} |
|||
⚫ | |||
| ChemSpiderID = 9127276 |
|||
| InChIKey = NJTAPFKGQYWFQM-WNQILTAPBM |
|||
| StdInChI_Ref = {{stdinchicite|changed|chemspider}} |
|||
| StdInChI = 1S/C29H48Br2O2/c1-17(2)8-7-9-18(3)21-10-11-22-20-16-24(30)26-27(31)25(33-19(4)32)13-15-29(26,6)23(20)12-14-28(21,22)5/h17-18,20-27H,7-16H2,1-6H3/t18-,20+,21-,22+,23+,24-,25?,26?,27-,28-,29-/m1/s1 |
|||
⚫ | |||
⚫ | |||
| StdInChIKey_Ref = {{stdinchicite|changed|chemspider}} |
|||
⚫ | |||
<!--Chemical data--> |
<!--Chemical data--> |
||
| chemical_formula = |
| chemical_formula = |
||
| C=29 | H=48 | Br=2 | O=2 |
| C=29 | H=48 | Br=2 | O=2 |
||
⚫ | |||
| molecular_weight = 588.498 g/mol |
|||
⚫ | |||
}} |
}} |
||
'''Acebrochol''' ([[International Nonproprietary Name|INN]]),<ref>{{cite web|title=INN - acebrochol|url=https://mednet-communities.net/inn/db/ViewINN.aspx?i=585|website=Mednet|publisher=Whorld Health Organisation (WHO)|access-date=10 August 2015}}</ref> also known as '''cholesteryl acetate dibromide''' or '''5α,6β-dibromocholestan-3β-ol acetate''', is a [[neuroactive steroid]] which was described as a [[sedative]] and [[hypnotic]] but was never marketed.<ref name="HillMakin1991">{{cite book| vauthors = Hill RA, Makin HL, Kirk DN, Murphy GM |title=Dictionary of Steroids|url=https://books.google.com/books?id=qw5X0NK1A90C&pg=PA229|date=23 May 1991|publisher=CRC Press|isbn=978-0-412-27060-4|pages=229–}}</ref> |
|||
'''Acebrochol''' ([[International Nonproprietary Name|INN]]) is a [[steroid]] drug with [[sedative]] effects. |
|||
==Chemistry== |
|||
{{See also|List of neurosteroids}} |
|||
==See also== |
|||
* [[Allopregnanolone]] |
|||
* [[Ganaxolone]] |
|||
* [[Hydroxydione]] |
|||
* [[Progesterone]] |
|||
==References== |
==References== |
||
{{Reflist|2}} |
|||
<references/> |
|||
⚫ | |||
{{GABAAR PAMs}} |
|||
[[Category:Cholestanes]] |
|||
⚫ | |||
[[Category:Hypnotics]] |
|||
[[Category:Sedatives]] |
[[Category:Sedatives]] |
||
[[Category: |
[[Category:Neurosteroids]] |
||
[[Category:Acetate esters]] |
[[Category:Acetate esters]] |
||
[[Category:GABAA receptor positive allosteric modulators]] |
|||